2026-2031 Global Nuclear Medicine & Radiopharmaceuticals Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

February 2026 | 140 pages | ID: N43924A18350EN
HNY RESEARCH

US$ 3,150.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
HNY Research projects that the Nuclear Medicine & Radiopharmaceuticals market size will grow from 6744.78 Million USD in 2025 to 11001.9 Million USD by 2031, at an estimated CAGR of 8.5%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.

For 2025 regional market size, the North America market size was 1682.15 Million USD, the Europe market size was 1002.95 Million USD, and the Asia market size was 1639.66 Million USD.

This report presents a detailed and holistic analysis of the global Nuclear Medicine & Radiopharmaceuticals market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.

All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.

Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.

Ultimately, this report serves as a vital resource for Nuclear Medicine & Radiopharmaceuticals manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.

By Market Players:

Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Dongcheng

By Type

Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals

By Application

Oncology
Thyroid
Cardiology
Others

By Regions/Countries:

North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America

Points Covered in The Report
  • The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
  • The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
  • The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
  • Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
  • The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
  • To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
  • Assess the production processes, major issues, and solutions to mitigate the development risk.
  • To understand the most affecting driving and restraining forces in the market and its impact in the global market.
  • Learn about the market strategies that are being adopted by leading respective organizations.
  • To understand the future outlook and prospects for the market.
  • Besides the standard structure reports, we also provide custom research according to specific requirements.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nuclear Medicine & Radiopharmaceuticals Revenue
1.4 Market Analysis by Type
  1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type: 2026-2031
  1.4.2 Diagnostic Radiopharmaceuticals
  1.4.3 Therapeutic Radiopharmaceuticals
1.5 Market by Application
  1.5.1 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Application: 2026-2031
  1.5.2 Oncology
  1.5.3 Thyroid
  1.5.4 Cardiology
  1.5.5 Others
1.6 Study Objectives
1.7 Overview of Global Nuclear Medicine & Radiopharmaceuticals Market
  1.7.1 Global Nuclear Medicine & Radiopharmaceuticals Market Status and Outlook (2020-2031)
  1.7.2 North America
  1.7.3 East Asia
  1.7.4 Europe
  1.7.5 South Asia
  1.7.6 Southeast Asia
  1.7.7 Middle East
  1.7.8 Africa
  1.7.9 Oceania
  1.7.10 South America
  1.7.11 Rest of the World

2 MANUFACTURING COST STRUCTURE ANALYSIS

2.1 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals
2.2 Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals

3 MARKET COMPETITION BY MANUFACTURERS

3.1 Global Nuclear Medicine & Radiopharmaceuticals Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Manufacturers (2020-2025)

4 NUCLEAR MEDICINE & RADIOPHARMACEUTICALS REGIONAL MARKET ANALYSIS

4.1 Nuclear Medicine & Radiopharmaceuticals Production by Regions
  4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Production by Regions (2020-2025)
  4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Regions
4.2 Nuclear Medicine & Radiopharmaceuticals Consumption by Regions
4.3 North America Nuclear Medicine & Radiopharmaceuticals Market Analysis
  4.3.1 North America Nuclear Medicine & Radiopharmaceuticals Production
  4.3.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue
  4.3.3 Key Manufacturers in North America
  4.3.4 North America Nuclear Medicine & Radiopharmaceuticals Import and Export
4.4 East Asia Nuclear Medicine & Radiopharmaceuticals Market Analysis
  4.4.1 East Asia Nuclear Medicine & Radiopharmaceuticals Production
  4.4.2 East Asia Nuclear Medicine & Radiopharmaceuticals Revenue
  4.4.3 Key Manufacturers in East Asia
  4.4.4 East Asia Nuclear Medicine & Radiopharmaceuticals Import & Export
4.5 Europe Nuclear Medicine & Radiopharmaceuticals Market Analysis
  4.5.1 Europe Nuclear Medicine & Radiopharmaceuticals Production
  4.5.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue
  4.5.3 Key Manufacturers in Europe
  4.5.4 Europe Nuclear Medicine & Radiopharmaceuticals Import & Export
4.6 South Asia Nuclear Medicine & Radiopharmaceuticals Market Analysis
  4.6.1 South Asia Nuclear Medicine & Radiopharmaceuticals Production
  4.6.2 South Asia Nuclear Medicine & Radiopharmaceuticals Revenue
  4.6.3 Key Manufacturers in South Asia
  4.6.4 South Asia Nuclear Medicine & Radiopharmaceuticals Import & Export
4.7 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Market Analysis
  4.7.1 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Production
  4.7.2 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue
  4.7.3 Key Manufacturers in Southeast Asia
  4.7.4 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Import & Export
4.8 Middle East Nuclear Medicine & Radiopharmaceuticals Market Analysis
  4.8.1 Middle East Nuclear Medicine & Radiopharmaceuticals Production
  4.8.2 Middle East Nuclear Medicine & Radiopharmaceuticals Revenue
  4.8.3 Key Manufacturers in Middle East
  4.8.4 Middle East Nuclear Medicine & Radiopharmaceuticals Import & Export
4.9 Africa Nuclear Medicine & Radiopharmaceuticals Market Analysis
  4.9.1 Africa Nuclear Medicine & Radiopharmaceuticals Production
  4.9.2 Africa Nuclear Medicine & Radiopharmaceuticals Revenue
  4.9.3 Key Manufacturers in Africa
  4.9.4 Africa Nuclear Medicine & Radiopharmaceuticals Import & Export
4.10 Oceania Nuclear Medicine & Radiopharmaceuticals Market Analysis
  4.10.1 Oceania Nuclear Medicine & Radiopharmaceuticals Production
  4.10.2 Oceania Nuclear Medicine & Radiopharmaceuticals Revenue
  4.10.3 Key Manufacturers in Oceania
  4.10.4 Oceania Nuclear Medicine & Radiopharmaceuticals Import & Export
4.11 South America Nuclear Medicine & Radiopharmaceuticals Market Analysis
  4.11.1 South America Nuclear Medicine & Radiopharmaceuticals Production
  4.11.2 South America Nuclear Medicine & Radiopharmaceuticals Revenue
  4.11.3 Key Manufacturers in South America
  4.11.4 South America Nuclear Medicine & Radiopharmaceuticals Import & Export

5 NUCLEAR MEDICINE & RADIOPHARMACEUTICALS SALES MARKET BY TYPE (2020-2031)

5.1 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Size by Type (2020-2025)
5.2 Global Nuclear Medicine & Radiopharmaceuticals Forecasted Market Size by Type (2026-2031)

6 NUCLEAR MEDICINE & RADIOPHARMACEUTICALS CONSUMPTION MARKET BY APPLICATION(2020-2031)

6.1 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Size by Application (2020-2025)
6.2 Global Nuclear Medicine & Radiopharmaceuticals Forecasted Market Size by Application (2026-2031)

7 COMPANY PROFILES AND KEY FIGURES IN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS BUSINESS

7.1 Cardinal Health
  7.1.1 Cardinal Health Company Profile
  7.1.2 Cardinal Health Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.1.3 Cardinal Health Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 GE Healthcare
  7.2.1 GE Healthcare Company Profile
  7.2.2 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.2.3 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Jubilant Pharma
  7.3.1 Jubilant Pharma Company Profile
  7.3.2 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.3.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 Novartis
  7.4.1 Novartis Company Profile
  7.4.2 Novartis Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.4.3 Novartis Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Curium Pharma
  7.5.1 Curium Pharma Company Profile
  7.5.2 Curium Pharma Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.5.3 Curium Pharma Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 SIEMENS
  7.6.1 SIEMENS Company Profile
  7.6.2 SIEMENS Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.6.3 SIEMENS Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 Lantheus
  7.7.1 Lantheus Company Profile
  7.7.2 Lantheus Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.7.3 Lantheus Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 Bracco Imaging
  7.8.1 Bracco Imaging Company Profile
  7.8.2 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.8.3 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.9 Bayer
  7.9.1 Bayer Company Profile
  7.9.2 Bayer Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.9.3 Bayer Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.10 Eli Lilly
  7.10.1 Eli Lilly Company Profile
  7.10.2 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.10.3 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.11 Aurobindo Pharma
  7.11.1 Aurobindo Pharma Company Profile
  7.11.2 Aurobindo Pharma Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.11.3 Aurobindo Pharma Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.12 Mundipharma
  7.12.1 Mundipharma Company Profile
  7.12.2 Mundipharma Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.12.3 Mundipharma Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.13 China Isotope & Radiation
  7.13.1 China Isotope & Radiation Company Profile
  7.13.2 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.13.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.14 Dongcheng
  7.14.1 Dongcheng Company Profile
  7.14.2 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Specification
  7.14.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)

8 PRODUCTION AND SUPPLY FORECAST

8.1 Global Forecasted Production of Nuclear Medicine & Radiopharmaceuticals (2026-2031)
8.2 Global Forecasted Revenue of Nuclear Medicine & Radiopharmaceuticals (2026-2031)
8.3 Global Forecasted Price of Nuclear Medicine & Radiopharmaceuticals (2020-2031)
8.4 Global Forecasted Production of Nuclear Medicine & Radiopharmaceuticals by Region (2026-2031)
  8.4.1 North America Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2026-2031)
  8.4.2 East Asia Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2026-2031)
  8.4.3 Europe Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2026-2031)
  8.4.4 South Asia Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2026-2031)
  8.4.5 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2026-2031)
  8.4.6 Middle East Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2026-2031)
  8.4.7 Africa Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2026-2031)
  8.4.8 Oceania Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2026-2031)
  8.4.9 South America Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2026-2031)
  8.4.10 Rest of the World Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
  8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
  8.5.2 Global Forecasted Consumption of Nuclear Medicine & Radiopharmaceuticals by Application (2026-2031)

9 CONSUMPTION AND DEMAND FORECAST

9.1 North America Forecasted Consumption of Nuclear Medicine & Radiopharmaceuticals by Country
9.2 East Asia Market Forecasted Consumption of Nuclear Medicine & Radiopharmaceuticals by Country
9.3 Europe Market Forecasted Consumption of Nuclear Medicine & Radiopharmaceuticals by Countriy
9.4 South Asia Forecasted Consumption of Nuclear Medicine & Radiopharmaceuticals by Country
9.5 Southeast Asia Forecasted Consumption of Nuclear Medicine & Radiopharmaceuticals by Country
9.6 Middle East Forecasted Consumption of Nuclear Medicine & Radiopharmaceuticals by Country
9.7 Africa Forecasted Consumption of Nuclear Medicine & Radiopharmaceuticals by Country
9.8 Oceania Forecasted Consumption of Nuclear Medicine & Radiopharmaceuticals by Country
9.9 South America Forecasted Consumption of Nuclear Medicine & Radiopharmaceuticals by Country
9.10 Rest of the world Forecasted Consumption of Nuclear Medicine & Radiopharmaceuticals by Country

10 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

10.1 Marketing Channel
  10.1.1 Direct Channels
  10.1.2 Indirect Channels

11 MARKET DYNAMICS

11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis

12 CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
LIST OF TABLES

Key Players Covered: Ranking by Nuclear Medicine & Radiopharmaceuticals Revenue 2020-2025
Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type: 2026-2031
Global Nuclear Medicine & Radiopharmaceuticals Market Size by Application: 2026-2031
Nuclear Medicine & Radiopharmaceuticals Production Rank and Commercial Production Date of Key Manufacturers
Global Nuclear Medicine & Radiopharmaceuticals Manufacturing Plants Distribution and Commercial Production Date
Global Nuclear Medicine & Radiopharmaceuticals Production Capacity by Manufacturers
Global Nuclear Medicine & Radiopharmaceuticals Production by Manufacturers (2020-2025)
Global Nuclear Medicine & Radiopharmaceuticals Production Market Share by Manufacturers (2020-2025)
Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers (2020-2025)
Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Global Market Nuclear Medicine & Radiopharmaceuticals Average Price of Key Manufacturers (2020-2025)
Manufacturers Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
Global Nuclear Medicine & Radiopharmaceuticals Production by Regions (2020-2025)
Global Nuclear Medicine & Radiopharmaceuticals Production Market Share by Regions (2020-2025)
Global Nuclear Medicine & Radiopharmaceuticals Revenue by Regions (2020-2025)
Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions (2020-2025)
Global Nuclear Medicine & Radiopharmaceuticals Consumption by Regions (2020-2025)
Global Nuclear Medicine & Radiopharmaceuticals Consumption Market Share by Regions (2020-2025)
Key Nuclear Medicine & Radiopharmaceuticals Players Sales Volume in North America
North America Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export
Key Nuclear Medicine & Radiopharmaceuticals Players Sales Volume in East Asia
East Asia Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export
Key Nuclear Medicine & Radiopharmaceuticals Players Sales Volume in Europe
Europe Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export
Key Nuclear Medicine & Radiopharmaceuticals Players Sales Volume in South Asia
South Asia Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export
Key Nuclear Medicine & Radiopharmaceuticals Players Sales Volume in Southeast Asia
Southeast Asia Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export
Key Nuclear Medicine & Radiopharmaceuticals Players Sales Volume in Middle East
Middle East Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export
Key Nuclear Medicine & Radiopharmaceuticals Players Sales Volume in Africa
Africa Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export
Key Nuclear Medicine & Radiopharmaceuticals Players Sales Volume in Oceania
Oceania Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export
Key Nuclear Medicine & Radiopharmaceuticals Players Sales Volume in South America
South America Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export
Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type (2020-2025)
Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2020-2025)
Global Nuclear Medicine & Radiopharmaceuticals Forecasted Market Size by Type (2026-2031)
Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2026-2031)
Global Nuclear Medicine & Radiopharmaceuticals Market Size by Application (2020-2025)
Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2020-2025)
Global Nuclear Medicine & Radiopharmaceuticals Forecasted Market Size by Application (2026-2031)
Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2026-2031)
Cardinal Health Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
GE Healthcare Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Table Novartis Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Curium Pharma Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
SIEMENS Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Lantheus Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Bayer Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Eli Lilly Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Aurobindo Pharma Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Mundipharma Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Dongcheng Nuclear Medicine & Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Global Nuclear Medicine & Radiopharmaceuticals Production Forecast by Region (2026-2031)
Global Nuclear Medicine & Radiopharmaceuticals Sales Volume Forecast by Type (2026-2031)
Global Nuclear Medicine & Radiopharmaceuticals Sales Volume Market Share Forecast by Type (2026-2031)
Global Nuclear Medicine & Radiopharmaceuticals Sales Revenue Forecast by Type (2026-2031)
Global Nuclear Medicine & Radiopharmaceuticals Sales Revenue Market Share Forecast by Type (2026-2031)
Global Nuclear Medicine & Radiopharmaceuticals Sales Price Forecast by Type (2026-2031)
Global Nuclear Medicine & Radiopharmaceuticals Consumption Volume Forecast by Application (2026-2031)
Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Forecast by Application (2026-2031)
North America Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031 by Country
East Asia Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031 by Country
Europe Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031 by Country
South Asia Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031 by Country
Southeast Asia Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031 by Country
Middle East Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031 by Country
Africa Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031 by Country
Oceania Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031 by Country
South America Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031 by Country
Rest of the world Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031 by Country
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2026-2031)
Key Challenges
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources



Global Nuclear Medicine & Radiopharmaceuticals Market Share by Type: 2025 VS 2031
Diagnostic Radiopharmaceuticals Features
Therapeutic Radiopharmaceuticals Features
Global Nuclear Medicine & Radiopharmaceuticals Market Share by Application: 2025 VS 2031
Oncology Case Studies
Thyroid Case Studies
Cardiology Case Studies
Others Case Studies
Nuclear Medicine & Radiopharmaceuticals Report Years Considered
Global Nuclear Medicine & Radiopharmaceuticals Market Status and Outlook (2020-2031)
North America Nuclear Medicine & Radiopharmaceuticals Revenue (Value) and Growth Rate (2020-2031)
East Asia Nuclear Medicine & Radiopharmaceuticals Revenue (Value) and Growth Rate (2020-2031)
Europe Nuclear Medicine & Radiopharmaceuticals Revenue (Value) and Growth Rate (2020-2031)
South Asia Nuclear Medicine & Radiopharmaceuticals Revenue (Value) and Growth Rate (2020-2031)
South America Nuclear Medicine & Radiopharmaceuticals Revenue (Value) and Growth Rate (2020-2031)
Middle East Nuclear Medicine & Radiopharmaceuticals Revenue (Value) and Growth Rate (2020-2031)
Africa Nuclear Medicine & Radiopharmaceuticals Revenue (Value) and Growth Rate (2020-2031)
Oceania Nuclear Medicine & Radiopharmaceuticals Revenue (Value) and Growth Rate (2020-2031)
South America Nuclear Medicine & Radiopharmaceuticals Revenue (Value) and Growth Rate (2020-2031)
Rest of the World Nuclear Medicine & Radiopharmaceuticals Revenue (Value) and Growth Rate (2020-2031)
Global Nuclear Medicine & Radiopharmaceuticals Revenue (2020-2031)
Global Nuclear Medicine & Radiopharmaceuticals Production Capacity (2020-2031)
Global Nuclear Medicine & Radiopharmaceuticals Production (2020-2031)
Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals in 2025
Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals
Global Nuclear Medicine & Radiopharmaceuticals Production Market Share by Regions in 2025
Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions in 2025
North America Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2020-2025
North America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2020-2025
East Asia Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2020-2025
East Asia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2020-2025
Europe Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2020-2025
Europe Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2020-2025
South Asia Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2020-2025
South Asia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2020-2025
Southeast Asia Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2020-2025
Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2020-2025
Middle East Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2020-2025
Middle East Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2020-2025
Africa Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2020-2025
Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2020-2025
Oceania Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2020-2025
Oceania Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2020-2025
South America Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2020-2025
South America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2020-2025
Cardinal Health Nuclear Medicine & Radiopharmaceuticals Product Specification
GE Healthcare Nuclear Medicine & Radiopharmaceuticals Product Specification
Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Product Specification
Novartis Nuclear Medicine & Radiopharmaceuticals Product Specification
Curium Pharma Nuclear Medicine & Radiopharmaceuticals Product Specification
SIEMENS Nuclear Medicine & Radiopharmaceuticals Product Specification
Lantheus Nuclear Medicine & Radiopharmaceuticals Product Specification
Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Product Specification
Bayer Nuclear Medicine & Radiopharmaceuticals Product Specification
Eli Lilly Nuclear Medicine & Radiopharmaceuticals Product Specification
Aurobindo Pharma Nuclear Medicine & Radiopharmaceuticals Product Specification
Mundipharma Nuclear Medicine & Radiopharmaceuticals Product Specification
China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Specification
Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Specification
Global Nuclear Medicine & Radiopharmaceuticals Production Capacity Growth Rate Forecast (2026-2031)
Global Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2026-2031)
Global Nuclear Medicine & Radiopharmaceuticals Price and Trend Forecast (2020-2031)
North America Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast (2026-2031)
North America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2026-2031)
East Asia Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast (2026-2031)
East Asia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2026-2031)
Europe Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast (2026-2031)
Europe Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2026-2031)
South Asia Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast (2026-2031)
South Asia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2026-2031)
Southeast Asia Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast (2026-2031)
Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2026-2031)
Middle East Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast (2026-2031)
Middle East Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2026-2031)
Africa Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast (2026-2031)
Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2026-2031)
Oceania Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast (2026-2031)
Oceania Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2026-2031)
South America Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast (2026-2031)
South America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2026-2031)
Rest of the World Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast (2026-2031)
Rest of the World Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2026-2031)
North America Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031
East Asia Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031
Europe Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031
South Asia Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031
Southeast Asia Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031
Middle East Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031
Africa Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031
Oceania Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031
South America Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031
Rest of the world Nuclear Medicine & Radiopharmaceuticals Consumption Forecast 2026-2031
Channels of Distribution
Porter's Five Forces Analysis
Key Executives Interviewed



More Publications